$20.02
-0.03-0.15%
At close: -
$20.02
0.000.00%
After Hours: 4:00 PM EDT
Comments
Loading...
Kiniksa Pharmaceuticals Insider Trading Activity | NASDAQ:KNSA | Benzinga
Track the latest Kiniksa Pharmaceuticals insider trading activity. Stay informed on recent buys, sells, and market impact for Kiniksa Pharmaceuticals stock.
What is Insider Activity?
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.
What are Kiniksa Pharmaceuticals International PLC Insiders Doing?
At Kiniksa Pharmaceuticals International PLC, recent insider activity has drawn attention. Over the last 30 days, insiders have reported selling a total of 5.00K shares worth $219.21K, meanwhile, insiders have report no purchases in the last 30 days.
Notable Recent Insider Buys and Sales
- On April 16, 2025, Eben Tessari, the company's CHIEF OPERATING OFFICER sold 5K shares for $12.14 each.
- On March 12, 2025, Eben Tessari, the company's CHIEF OPERATING OFFICER sold 5.41K shares for $12.43 each.
- On February 12, 2025, Eben Tessari, the company's CHIEF OPERATING OFFICER sold 7K shares for $11.69 each.
Ownership Statistics for Kiniksa Pharmaceuticals International PLC
Shares Outstanding
72.644M
Insider Shares Owned
857.178K
Insider Percentage Owned
1.18%
Institutional Shares Held
17.968M
Institutional Percentage Held
24.7%
| Apr 16, 2025 | Eben Tessari | CHIEF OPERATING OFFICER | -5.00K | $12.14 | -$219.21K | SELL | -6.07% | 77.36K | Apr 14 | View |
| Mar 24, 2025 | Mark Ragosa | CHIEF FINANCIAL OFFICER | 0.00 | $18.04 | -$161.67K | SELL-OPTIONS | 0.00% | 23.38K | Mar 20 | View |
| Mar 19, 2025 | Mark Ragosa | CHIEF FINANCIAL OFFICER | 424.00 | $18.03 | -$216.20K | SELL-OPTIONS | 1.85% | 23.38K | Mar 16 - Mar 19 | View |
| Mar 14, 2025 | Michael Megna | CHIEF ACCOUNTING OFFICER | 0.00 | $16.77 | -$102.73K | SELL-OPTIONS | 0.00% | 26.53K | Mar 12 | View |
| Mar 14, 2025 | Mark Ragosa | CHIEF FINANCIAL OFFICER | 0.00 | $17.11 | -$373.90K | SELL-OPTIONS | 0.00% | 22.96K | Mar 12 | View |
| Mar 12, 2025 | Eben Tessari | CHIEF OPERATING OFFICER | -5.41K | $12.43 | -$234.73K | SELL | -6.60% | 76.57K | Mar 10 | View |
| Feb 12, 2025 | Eben Tessari | CHIEF OPERATING OFFICER | -7.00K | $11.69 | -$247.38K | SELL | -7.87% | 81.97K | Feb 10 | View |
| Jan 15, 2025 | Eben Tessari | CHIEF OPERATING OFFICER | -7.00K | $11.02 | -$228.81K | SELL | -7.29% | 88.97K | Jan 13 | View |
| Dec 18, 2024 | Eben Tessari | CHIEF OPERATING OFFICER | -7.00K | $11.02 | -$445.00K | SELL | -6.80% | 95.97K | Dec 16 | View |
| Dec 10, 2024 | Mark Ragosa | CHIEF FINANCIAL OFFICER | -6.56K | $16.20 | -$358.76K | SELL | -22.23% | 22.96K | Dec 06 - Dec 09 | View |
| Dec 05, 2024 | Mark Ragosa | CHIEF FINANCIAL OFFICER | 0.00 | $16.06 | -$160.36K | SELL-OPTIONS | 0.00% | 22.96K | Dec 03 - Dec 05 | View |
| Dec 02, 2024 | Michael Megna | CHIEF ACCOUNTING OFFICER | 0.00 | $16.77 | -$98.13K | SELL-OPTIONS | 0.00% | 26.53K | Nov 27 - Nov 29 | View |
| Nov 20, 2024 | Eben Tessari | CHIEF OPERATING OFFICER | -7.00K | $11.31 | -$341.78K | SELL | -6.37% | 102.97K | Nov 18 | View |
| Nov 08, 2024 | Sanj Patel | CHAIRMAN & CEO | 0.00 | $12.29 | -$1.92M | SELL-OPTIONS | 0.00% | 189.35K | Nov 06 | View |
| Oct 17, 2024 | Eben Tessari | CHIEF OPERATING OFFICER | -7.00K | $14.23 | -$440.89K | SELL | -5.98% | 109.97K | Oct 15 | View |
| Sep 25, 2024 | Eben Tessari | CHIEF OPERATING OFFICER | -7.50K | $13.29 | -$421.43K | SELL | -6.03% | 116.97K | Sep 23 | View |
| Sep 04, 2024 | John Paolini | CHIEF MEDICAL OFFICER | 3.02K | $14.01 | -$1.55M | SELL-OPTIONS | 6.15% | 52.04K | Sep 01 - Sep 03 | View |
| Sep 04, 2024 | Ross Moat | CHIEF COMMERCIAL OFFICER | 3.56K | $18.55 | -$1.08M | SELL-OPTIONS | 19.56% | 21.74K | Jul 15 - Sep 03 | View |
| Aug 29, 2024 | Eben Tessari | CHIEF OPERATING OFFICER | -7.50K | $14.25 | -$455.02K | SELL | -5.89% | 119.91K | Aug 27 | View |
| Jul 25, 2024 | Sanj Patel | CHAIRMAN & CEO | 0.00 | $13.62 | -$3.28M | SELL-OPTIONS | 0.00% | 172.81K | Jul 23 | View |
| Jul 25, 2024 | Mark Ragosa | CHIEF FINANCIAL OFFICER | 0.00 | $17.94 | -$331.96K | SELL-OPTIONS | 0.00% | 19.25K | Jul 23 | View |
| Jul 25, 2024 | John Paolini | CHIEF MEDICAL OFFICER | 0.00 | $14.09 | -$538.05K | SELL-OPTIONS | 0.00% | 47.80K | Jul 23 | View |
| Mar 11, 2024 | Sanj Patel | CHAIRMAN & CEO | -65.01K | $21.02 | -$1.37M | SELL | -55.32% | 52.52K | Mar 07 | View |
| Mar 06, 2024 | Sanj Patel | CHAIRMAN & CEO | -18.32K | $21.34 | -$391.06K | SELL | -13.49% | 117.53K | Mar 04 - Mar 06 | View |
| Mar 05, 2024 | Eben Tessari | CHIEF OPERATING OFFICER | -533.00 | $11.81 | -$25.15K | SELL | -0.43% | 122.85K | Mar 01 | View |
| Mar 05, 2024 | John Paolini | CHIEF MEDICAL OFFICER | 0.00 | $11.81 | -$375.18K | SELL-OPTIONS | 0.00% | 44.89K | Mar 01 | View |
| Mar 01, 2024 | Michael Megna | CHIEF ACCOUNTING OFFICER | 583.00 | $15.93 | -$160.86K | SELL-OPTIONS | 3.43% | 17.59K | Jan 15 - Mar 01 | View |
| Feb 29, 2024 | John Paolini | CHIEF MEDICAL OFFICER | 0.00 | $11.45 | -$194.69K | SELL-OPTIONS | 0.00% | 44.89K | Feb 27 | View |
| Jan 04, 2024 | Mark Ragosa | CHIEF FINANCIAL OFFICER | 0.00 | $14.41 | -$134.04K | SELL-OPTIONS | 0.00% | 15.63K | Jan 03 | View |
| Jan 04, 2024 | Michael Megna | CHIEF ACCOUNTING OFFICER | 0.00 | $16.53 | -$88.18K | SELL-OPTIONS | 0.00% | 17.00K | Jan 02 | View |
| Dec 21, 2023 | Michael Megna | CHIEF ACCOUNTING OFFICER | 0.00 | $16.50 | -$48.91K | SELL-OPTIONS | 0.00% | 17.00K | Dec 19 | View |
| Dec 11, 2023 | John Paolini | CHIEF MEDICAL OFFICER | 0.00 | $9.75 | -$451.56K | SELL-OPTIONS | 0.00% | 44.89K | Dec 07 | View |
| Sep 06, 2023 | John Paolini | CHIEF MEDICAL OFFICER | 2.98K | $9.78 | -$28.31K | SELL-OPTIONS | 7.12% | 44.89K | Sep 01 - Sep 05 | View |
| Jul 27, 2023 | John Paolini | CHIEF MEDICAL OFFICER | 0.00 | $10.50 | -$501.22K | SELL-OPTIONS | 0.00% | 41.91K | Jul 25 | View |
| Dec 01, 2022 | Barry Quart | — | 0.00 | $8.87 | -$319.72K | SELL-OPTIONS | 0.00% | 0.00 | Nov 29 | View |
| Nov 09, 2022 | John Paolini | CHIEF MEDICAL OFFICER | 0.00 | $8.52 | -$377.72K | SELL-OPTIONS | 0.00% | 36.34K | Nov 07 | View |
| Feb 10, 2021 | Sanj K Patel | CHAIRMAN & CEO | -29.23K | $12.32 | -$1.25M | SELL | -13.15% | 193.13K | Feb 08 - Feb 10 | View |
| Feb 05, 2021 | Thomas W Beetham | EVP & CHIEF LEGAL OFFICER | 297.52K | $22.09 | -$54.72K | SELL-OPTIONS | ∞ | 297.52K | Feb 03 | View |
| Oct 14, 2020 | Sanj K Patel | — | -100.00K | $11.30 | -$5.05M | OPTION EXERCISE | -31.02% | 222.37K | Oct 09 - Oct 12 | View |
| Jul 02, 2020 | Thomas W Beetham | — | -29.59K | $25.37 | -$750.68K | SELL | -100.00% | 0.00 | Jul 01 | View |
| Jun 12, 2020 | Thomas W Beetham | — | 0.00 | $13.33 | -$322.90K | OPTION EXERCISE | 0.00% | 29.59K | Jun 10 | View |
FAQ
Is insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.
